Resultados de procura - Chin‐Yang Li

Limitar resultados
  1. 1
    Systemic mast cell disease: A clinical and hematopathologic study of 26 cases

    Systemic mast cell disease: A clinical and hematopathologic study of 26 cases por Thomas A. Webb, Chin‐Yang Li, Lung T. Yam

    Publicado 1982
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  2. 2
    Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes

    Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes por Ronald S. Go, Chin‐Yang Li, Ayalew Tefferi, Robert L. Phyliky

    Publicado 2001
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    Treatment of Systemic Mast-Cell Disease with Cladribine

    Treatment of Systemic Mast-Cell Disease with Cladribine por Ayalew Tefferi, Chin‐Yang Li, Joseph H. Butterfield, H. Clark Hoagland

    Publicado 2001
    Ligazón do recurso Ligazón do recurso
    Carta
    Engadir a favoritos
    Gardado en:
  4. 4
    Epstein-Barr virus infection in Richter's transformation

    Epstein-Barr virus infection in Richter's transformation por Stephen M. Ansell, Chin‐Yang Li, Ricardo V. Lloyd, Robert L. Phyliky

    Publicado 1999
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Cytoreductive therapy in 108 adults with systemic mastocytosis: Outcome analysis and response prediction during treatment with interferon‐alpha, hydroxyurea, imatinib mesylate or 2‐chlorodeoxyadenosine

    Cytoreductive therapy in 108 adults with systemic mastocytosis: Outcome analysis and response prediction during treatment with interferon‐alpha, hydroxyurea, imatinib mesylate or 2... por Ken Hong Lim, Animesh Pardanani, Joseph H. Butterfield, Chin‐Yang Li, Ayalew Tefferi

    Publicado 2009
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Systemic Mast Cell Disease

    Systemic Mast Cell Disease por William D. Travis, Chin‐Yang Li, Erik J. Bergstralh, Lung T. Yam, Ronald G. Swee

    Publicado 1988
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Etanercept, a soluble tumor necrosis factor receptor, palliates constitutional symptoms in patients with myelofibrosis with myeloid metaplasia: results of a pilot study

    Etanercept, a soluble tumor necrosis factor receptor, palliates constitutional symptoms in patients with myelofibrosis with myeloid metaplasia: results of a pilot study por David P. Steensma, Ruben A. Mesa, Chin‐Yang Li, Leigh A. Gray, Ayalew Tefferi

    Publicado 2002
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Significance of systemic mast cell disease with associated hematologic disorders

    Significance of systemic mast cell disease with associated hematologic disorders por William D. Travis, Chin‐Yang Li, Lung T. Yam, Erik J. Bergstralh, Ronald G. Swee

    Publicado 1988
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases

    Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases por Ruben A. Mesa, Chin‐Yang Li, Rhett P. Ketterling, Georgene Schroeder, Ryan A. Knudson, Ayalew Tefferi

    Publicado 2004
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia

    Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia por Ayalew Tefferi, Ruben A. Mesa, Georgene Schroeder, Curtis A. Hanson, Chin‐Yang Li, Gordon W. Dewald

    Publicado 2001
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Validation and comparison of contemporary prognostic models in primary myelofibrosis

    Validation and comparison of contemporary prognostic models in primary myelofibrosis por Ayalew Tefferi, Jocelin Huang, Susan M. Schwager, Chin‐Yang Li, Wenting Wu, Animesh Pardanani, Ruben A. Mesa

    Publicado 2007
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    Risk factors for leukemic transformation in patients with primary myelofibrosis

    Risk factors for leukemic transformation in patients with primary myelofibrosis por Jocelin Huang, Chin‐Yang Li, Ruben A. Mesa, Wentling Wu, Curtis A. Hanson, Animesh Pardanani, Ayalew Tefferi

    Publicado 2008
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    WHO subvariants of indolent mastocytosis: clinical details and prognostic evaluation in 159 consecutive adults

    WHO subvariants of indolent mastocytosis: clinical details and prognostic evaluation in 159 consecutive adults por Animesh Pardanani, Ken-Hong Lim, Terra L. Lasho, Christy Finke, Rebecca F. McClure, Chin‐Yang Li, Ayalew Tefferi

    Publicado 2010
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    Thalidomide treatment in myelofibrosis with myeloid metaplasia

    Thalidomide treatment in myelofibrosis with myeloid metaplasia por Michelle A. Elliott, Ruben A. Mesa, Chin‐Yang Li, C. Christopher Hook, Stephen M. Ansell, Ralph Levitt, Susan M. Geyer, Ayalew Tefferi

    Publicado 2002
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    The <i>JAK2</i><sup>V617F</sup> tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlates

    The <i>JAK2</i><sup>V617F</sup> tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlates por Ayalew Tefferi, Terra L. Lasho, Susan M. Schwager, David P. Steensma, Ruben A. Mesa, Chin‐Yang Li, Martha Wadleigh, D. Gary Gilliland

    Publicado 2005
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    Lenalidomide and prednisone for myelofibrosis: Eastern Cooperative Oncology Group (ECOG) phase 2 trial E4903

    Lenalidomide and prednisone for myelofibrosis: Eastern Cooperative Oncology Group (ECOG) phase 2 trial E4903 por Ruben A. Mesa, Xiaopan Yao, Larry D. Cripe, Chin Yang Li, Mark R. Litzow, Elisabeth Paietta, Jacob M. Rowe, Ayalew Tefferi, Martin S. Tallman

    Publicado 2010
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors

    Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors por Ken-Hong Lim, Ayalew Tefferi, Terra L. Lasho, Christy Finke, Mrinal M. Patnaik, Joseph H. Butterfield, Rebecca F. McClure, Chin‐Yang Li, Animesh Pardanani

    Publicado 2009
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    Clinical correlates of <i>JAK2</i>V617F allele burden in essential thrombocythemia

    Clinical correlates of <i>JAK2</i>V617F allele burden in essential thrombocythemia por Jaya Kittur, Ryan A. Knudson, Terra L. Lasho, Christy Finke, Naseema Gangat, Alexandra P. Wolanskyj, Chin‐Yang Li, Wenting Wu, Rhett P. Ketterling, Animesh Pardanani, Ayalew Tefferi

    Publicado 2007
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    Concomitant neutrophil <i>JAK2</i><sup>V617F</sup> mutation screening and <i>PRV‐1</i> expression analysis in myeloproliferative disorders and secondary polycythaemia

    Concomitant neutrophil <i>JAK2</i><sup>V617F</sup> mutation screening and <i>PRV‐1</i> expression analysis in myeloproliferative disorders and secondary polycythaemia por Ayalew Tefferi, Shireen Sirhan, Terra L. Lasho, Susan M. Schwager, Chin‐Yang Li, David Dingli, Alexandra P. Wolanskyj, David P. Steensma, Ruben A. Mesa, D. Gary Gilliland

    Publicado 2005
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia

    FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia por Animesh Pardanani, Stephanie R. Brockman, Sarah F. Paternoster, Heather C. Flynn, Rhett P. Ketterling, Terra L. Lasho, Ching-Liang Ho, Chin‐Yang Li, Gordon W. Dewald, Ayalew Tefferi

    Publicado 2004
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: